Marksans Pharma Board Meeting Scheduled for November 4, 2026
Marksans Pharma Ltd 路 Intimation 路 04 Nov 2026, 5:30 am
Marksans Pharma Board Meeting Scheduled for November 4, 2026 Marksans Pharma Ltd. announced that its Board of Directors will meet on 4th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company shares by designated persons and their immediate relatives has been closed from 1st Oct'26 and will remain closed until 6th Nov'26, 48 hours post the financial results announcement.
Original exchange filing (PDF)
More announcements from Marksans Pharma Ltd
- Transcript of Investors/Analyst meet on Q2 FY27 Financial Results 路 13 Nov 2026
- Audio Recording of investor(s)/analyst(s) meet Conference Call on Q2 FY 27 Financial Results 路 05 Nov 2026
- Allotment of Equity Shares under Marksans Employees Stock Option Scheme 2024 路 04 Nov 2026
- Press Release for Financial Results Q2FY27 路 04 Nov 2026
- Investor Presentation Q2FY27 路 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2026 路 04 Nov 2026
- Marksans Pharma Limited has submitted to the Exchange, unaudited financial results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Please find attached outcome of the Board meeting held on 04 November 2026 路 04 Nov 2026
